Oscar Health Analyst Ratings
Piper Sandler Maintains Oscar Health(OSCR.US) With Buy Rating, Maintains Target Price $28
Oscar Health (OSCR) Receives a Buy From Piper Sandler
Oscar Health Price Target Raised to $28.00/Share From $25.00 by Piper Sandler
Oscar Health Analyst Ratings
Buy Rating Affirmed: Oscar Health's Strong Financials Signal Continued Growth
Oscar Health Analyst Ratings
Piper Sandler Maintains Overweight on Oscar Health, Maintains $25 Price Target
Oscar Health Analyst Ratings
Oscar Health Analyst Ratings
Wells Fargo Maintains Overweight on Oscar Health, Raises Price Target to $27
B of A Securities Downgrades Oscar Health to Neutral, Lowers Price Target to $21
Oscar Health Analyst Ratings
Baird Initiates Coverage On Oscar Health With Outperform Rating, Announces Price Target of $28
Oscar Health Analyst Ratings
B of A Securities Maintains Buy on Oscar Health, Raises Price Target to $25
Analysts Offer Insights on Healthcare Companies: Oscar Health (OSCR), Puma Biotechnology (PBYI) and Patterson Companies (PDCO)
Wells Fargo: Maintaining the Oscar Health (OSCR.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $20.00 to $24.00.
Oscar Health Analyst Ratings
Goldman Sachs Maintains Neutral on Oscar Health, Raises Price Target to $21